Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of…
By Marilyn M. Li, M. Datto, E. Duncavage, S. Kulkarni, N. Lindeman, Somak Roy, A. Tsimberidou, C. Vnencak-Jones, D. Wolff, A. Younes and 1 more. Journal of Molecular Diagnostics, 2017
1,774 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/51499df0886a8516930e86abf727e25c1a5863f2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Genetics
In Pathology and Forensic Medicine
Citations in the corpus
- Molecular profiling for precision cancer therapies (2020, methodology): “The Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists have published a series of recommendations for the classification and reporting of somatic variants in cancer patients, which are based on their clinical significance and the availabl”
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. (2022, background): “In addition to general clinical molecular laboratory reporting recommendations, 43,44 recommended reporting elements and approaches with particular relevance to ctDNA assays are included in Table 1 and Supplementary Table S1, available at https://doi.org/10.1016/j.annonc.2022.05.520.”
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic (2018, background): “Normal germline variations in DNA sequence between individuals must be identified and removed from consideration in order to tabulate only the somatic alterations, a process that has been well-established [66, 67].”